Ifp Advisors, Inc Surface Oncology, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$1.42 - $3.15 $2,250 - $4,992	1,585 New	1,585 $22,000
Q2 2022 Aug 12, 2022	SELL	$1.42 - $3.15 $2,250 - $4,992	-1,585 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.65 - $5.08 $4,200 - $8,051	1,585 New	1,585 $4,000
Q3 2021 Oct 06, 2021	SELL	$5.16 - $7.98 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$6.45 - $9.09 $3,225 - $4,545	-500 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$7.25 - $13.82 $3,625 - $6,910	500 New	500 $4,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.